Immupharma Share Discussion Threads

[jpleight] 22/1/2018 09:58

market doesnt buy this optimism yet.

[stealth wealth] 22/1/2018 09:42

Looking at the numbers, Lupuzor has the potential to become the world's best selling drug. Only needs 650k patients out of the 2 million IMM's Tim McC says they could target, at $25k pa to give $16.25 billion pa sales, even without the other indications the P140 platform (of which Lupuzor is a part) could treat. If I know this, so will all the big pharmas with the money to do a very large deal or takeover.

N.B.
Abbvie’s Humira (adalimumab) is the world's best-selling drug with sales of US $16.078 billion in 2016. (Treats rheumatoid arthritis and Crohns, similar to IMM's P140 platform).

[ny boy] 22/1/2018 09:41

Usual posters pop up to spread doubt lol


Ignore the noise, if you had listened to many of them, you would have sold on each pull back since the 50p’s and going mad in a padded cell

As we get closer to end of March the share price will keep climbing, there will be tree shakes along the way to weed out the unwashed.

[w1ndjammer] 22/1/2018 09:19

No answer from kfp looks like he was just here to Tee up njb

WJ.

[melf] 22/1/2018 09:05

If such a situation arose here, I suppose the company would be able to provide more data from the follow up open label six month trial if necessary.

[greatfull dead] 22/1/2018 09:04

My strategy regards risk v reward, is the reason I have not gone over the top with my buys. Well in profit and have taken profit. When the opportunity comes and it will I will top slice for a free ride. I have missed it once but will not again.

GLA,
GD

[w1ndjammer] 22/1/2018 09:03

kfp

what was the name of the pharma you invested in, in post 10472

WJ.

[kfp] 22/1/2018 08:53

njb67

Agreed ,I was invested in a bio stock with people valuing it at £100 a share "as soon as p111 results come out",nothing wrong with the drug but the FDA asked for more data and the share price collapsed ,all the "experts" disappeared and the the share price languished for years because the company could not find any cash to carry on and had to sell the beat bit.

[jpleight] 22/1/2018 08:51

yes, they are :)

[njb67] 22/1/2018 08:51

KoP202

I believe so. However, they are not certain to be positive or sufficient to lead to FDA approval in 2018, something the ramping gang on here (conveniently) overlook.

One of the brokers was estimating a 63% chance of positive phase 3 results, although I have no idea on what basis they arrived at this figure.

GL.

[kop202] 22/1/2018 08:46

Njb67But in terms of probability there stacked in our favour....are they not?

[runtoma] 22/1/2018 08:42

I am staying with the one and only share price forecast I gave about a month ago - It will settle at between £10 and £20 a share in the months after a phase 3 positive readout and will be taken over for between £30 and £40 a share

[ny boy] 22/1/2018 08:38

Tick tock....

[ny boy] 22/1/2018 08:23

Resistance 190p, when that breaks, expect a powerful move higher

[greatfull dead] 22/1/2018 08:12

njb,

Your post is appreciated. Thank you.

ATB,
GD

[njb67] 22/1/2018 08:10

GD

I agree, I also do not think a take over is likely at this stage. Nothing much has changed in recent weeks and the commercial value/viability of IMM still depends on the phase three results.

I like the company optimism but until we see the results, nothing is in the bag. Plenty of medicines fail at phase three and plenty of chairman have talked up a company's prospects only for it to come crashing down around them.

ATB

[qs99] 22/1/2018 08:06

OK maybe market is going to start moving this north of £2, nice blue open

[hydrus] 22/1/2018 07:46

That was a typo sorry managed to simultaneously open the company forum and click 'x'. I don't have any views here!

[lukead] 22/1/2018 07:45

DAFAD, thanks, a 64% premium for a company which is already making $847 in sales (2016)

[greatfull dead] 22/1/2018 07:45

njb,

The last thing I personally want now is a takeover bid for IMM at this point in time. Let the results of the Phase 3 Lupuzor trial be fully analysed and the market informed correct via RNS of the results are back up by proven and unquestionable data.

No more guesstimates please. They have caused this thread to become similar to a circus.

ATB,
GD

[kevinjwsmith] 22/1/2018 07:37

Would we be likely to see any type of broker note upgrade this week or near future ?